Signaturefd LLC Has $146,000 Stake in Teleflex Incorporated (NYSE:TFX)

Signaturefd LLC lifted its stake in shares of Teleflex Incorporated (NYSE:TFX) by 49.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 587 shares of the medical technology company’s stock after buying an additional 195 shares during the quarter. Signaturefd LLC’s holdings in Teleflex were worth $146,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of TFX. Allworth Financial LP grew its position in shares of Teleflex by 332.3% during the 3rd quarter. Allworth Financial LP now owns 134 shares of the medical technology company’s stock worth $26,000 after buying an additional 103 shares during the period. Venturi Wealth Management LLC acquired a new stake in shares of Teleflex during the 3rd quarter worth approximately $27,000. Covestor Ltd grew its position in shares of Teleflex by 305.6% during the 3rd quarter. Covestor Ltd now owns 146 shares of the medical technology company’s stock worth $29,000 after buying an additional 110 shares during the period. Lindbrook Capital LLC grew its position in shares of Teleflex by 75.3% during the 4th quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company’s stock worth $34,000 after buying an additional 58 shares during the period. Finally, Massmutual Trust Co. FSB ADV grew its position in shares of Teleflex by 418.5% during the 4th quarter. Massmutual Trust Co. FSB ADV now owns 140 shares of the medical technology company’s stock worth $35,000 after buying an additional 113 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on TFX. Truist Financial reduced their price target on shares of Teleflex from $270.00 to $265.00 and set a “hold” rating for the company in a research report on Friday, February 23rd. StockNews.com downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 23rd. JMP Securities reissued a “market outperform” rating and issued a $285.00 price target on shares of Teleflex in a research report on Friday, February 23rd. Finally, Royal Bank of Canada reduced their price target on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a research report on Friday, February 23rd. Four investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $267.50.

Insiders Place Their Bets

In other Teleflex news, VP Cameron P. Hicks sold 7,401 shares of Teleflex stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total transaction of $1,665,225.00. Following the transaction, the vice president now directly owns 10,050 shares of the company’s stock, valued at approximately $2,261,250. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.43% of the company’s stock.

Teleflex Price Performance

TFX opened at $206.71 on Monday. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.32 and a quick ratio of 1.29. The company has a market capitalization of $9.74 billion, a price-to-earnings ratio of 27.45, a P/E/G ratio of 1.98 and a beta of 1.11. The firm’s fifty day moving average price is $221.23 and its two-hundred day moving average price is $226.03. Teleflex Incorporated has a 1 year low of $177.63 and a 1 year high of $276.43.

Teleflex (NYSE:TFX) last posted its quarterly earnings data on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.26 by $0.12. The firm had revenue of $773.90 million for the quarter, compared to the consensus estimate of $769.01 million. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. The business’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.52 EPS. As a group, analysts anticipate that Teleflex Incorporated will post 13.73 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date was Thursday, February 29th. Teleflex’s dividend payout ratio is 18.06%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.